Table 2.
Healthy volunteers | Antibody‐deficient patients | ||
---|---|---|---|
Typhim Vi® (U/ml) | Typhim Vi® (U/ml) | ||
Pre‐vaccination (U/ml) | n | 8* | 20* |
Range | < 7·4–14 | < 7·4–16 | |
Post‐vaccination U/ml) | n | 8 | 12 |
Median | 107 | 23 | |
range | 31–542 | 10–372 | |
Fold increase in concentration (FI) | |||
FI > 3 | 8/8 (100%) | 6/20 (30%) | |
FI > 10 | 6/8 (75%) | 2/20 (10%) |
Typhim Vi® antibodies were measured in serum samples obtained from healthy volunteers and antibody deficiency patients as described in the Materials and methods. *Three individuals with high baseline concentrations of Typhi Vi immunoglobulin (Ig)G were removed for generation of reference ranges.